Skip to main content
. 2001 May;158(5):1695–1701. doi: 10.1016/S0002-9440(10)64125-9

Figure 4.

Figure 4.

Loss of berberine sulfate-binding ability of mast cells in the mucosa 35 days after injection of 10 4 PMCs of WBB6F1-c-kit+/c-kit+; GFP+/GFP− mice into the stomach of WBB6F1-c-kitW/c-kitWv; GFP−/GFP− mice, despite of the maintenance of the original protease expression phenotype (MC-CPA+/mMCP-2+). A: Expression of MC-CPA mRNA by the mast cells in the mucosa was demonstrated by in situ hybridization. B: Expression of mMCP-2 mRNA by the mast cells in the mucosa. C: Mast cells in the mucosa stained with AB and nuclear fast red. D: An adjacent section of C. Mast cells in the mucosa were not stained with berberine sulfate. E: Mast cells in the muscularis propria stained with AB and nuclear fast red. F: An adjacent section of E. Mast cells in the muscularis propria were stained with berberine sulfate. Original magnification, ×300.